Clinical trial Recruiting at 1 site Interventional Ages 10 to 18

Schroth method with and without core stabilization exercises for adolescents with idiopathic scoliosis

Official title: Synergic Effects of Schroth Method With and Without Core Stabilization Exercises in Idiopathic Scoliosis Patients

Run by University of Lahore · NCT07059663 · Data updated 2026-11-12

This trial tests whether adding core stabilization exercises to the Schroth method helps teens (ages 10–18) with mild idiopathic scoliosis reduce spinal curve, build back endurance, increase chest mobility, and improve quality of life.

Quick facts

Study typeInterventional
Ages10 Years to 18 Years
SexAll
Enrollment72 (estimated)
SponsorUniversity of Lahore
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedJuly 30, 2025
Main results expectedSeptember 10, 2025
Study endsJanuary 30, 2026
Registry record updatedJuly 15, 2025
Trial IDNCT07059663 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents aged 10–18 with X-ray–confirmed idiopathic scoliosis and Cobb angles of 10°–30° who can attend supervised therapy sessions are ideal candidates.

Probably not a fit

Patients with non-idiopathic scoliosis, prior spinal surgery, major neurological conditions, significant orthopedic comorbidities, or severe systemic disease are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers randomized 30 adolescents (ages 10–18) with idiopathic scoliosis (Cobb angle 10–30°) at the University of Lahore Teaching Hospital to receive either the Schroth method plus core stabilization exercises or the Schroth method alone. Interventions were delivered three times weekly for ten weeks, with assessments at baseline, week 5, and week 10. Outcomes included Cobb angle, lumbar extensor endurance (Sorensen test), chest mobility, and SRS-22 quality-of-life scores. The trial reported improvements in both groups across these measures, with the combined Schroth-plus-core group showing larger gains.

Why it matters

Potential benefit: If successful, adding core stabilization to Schroth therapy could result in greater curve reduction, improved back endurance, better chest mobility, and higher quality-of-life for adolescents with mild idiopathic scoliosis.

How similar studies have gone: The Schroth method has prior supportive evidence for improving curve magnitude and quality of life in idiopathic scoliosis, and combining it with core-strengthening has biological plausibility though randomized evidence on the combined approach is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Age 10 to 18

  * X-ray diagnosed of idiopathic scoliosis with Cobb Angle 10˚- 30˚
  * Participants with Idiopathic Scoliosis
  * Both genders will be included
  * Scoliosis with Down syndrome.

Exclusion Criteria:

* Any neurological condition such as cerebral palsy or epilepsy.
* Any other orthopedic condition such as hip dysplasia, osteogenesis imperfecta, or leg length discrepancy.
* Surgical history of the spine, such as spinal fusion and decompression surgery.
* Severe systemic disorders such as autoimmune disorders, severe cardiovascular conditions
* Non-Idiopathic Scoliosis

Where it's running

  • UOL Teaching Hospital
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.